Validation of dynamic contrast-enhanced magnetic resonance imaging-derived vascular permeability measurements using quantitative autoradiography in the RG2 rat brain tumor model.
about
Inhibition of SUR1 decreases the vascular permeability of cerebral metastases.Focused ultrasound simultaneous irradiation/MRI imaging, and two-stage general kinetic model.Neoplasia: the second decade.Imaging biomarkers for antiangiogenic therapy in malignant gliomas.High resolution ultra high field magnetic resonance imaging of glioma microvascularity and hypoxia using ultra-small particles of iron oxideThe apparent diffusion coefficient does not reflect cytotoxic edema on the uninjured side after traumatic brain injuryModeling the effect of intra-voxel diffusion of contrast agent on the quantitative analysis of dynamic contrast enhanced magnetic resonance imaging.Dynamic magnetic resonance imaging assessment of vascular targeting agent effects in rat intracerebral tumor models.Reproducibility of magnetic resonance perfusion imagingRapid-Steady-State-T1 signal modeling during contrast agent extravasation: toward tumor blood volume quantification without requiring the arterial input function.Dynamic permeability and quantitative susceptibility: related imaging biomarkers in cerebral cavernous malformationsAssessment of blood-brain barrier disruption using dynamic contrast-enhanced MRI. A systematic review.Techniques and applications of dynamic contrast enhanced magnetic resonance imaging in cancerPrediction of radiosensitivity in primary central nervous system germ cell tumors using dynamic contrast-enhanced magnetic resonance imaging.Characterization of tumor angiogenesis in rat brain using iron-based vessel size index MRI in combination with gadolinium-based dynamic contrast-enhanced MRIEpithelial and mesenchymal tumor compartments exhibit in vivo complementary patterns of vascular perfusion and glucose metabolism.Vascular permeability in cerebral cavernous malformations.Magnetic resonance imaging profile of blood-brain barrier injury in patients with acute intracerebral hemorrhageEffective transvascular delivery of nanoparticles across the blood-brain tumor barrier into malignant glioma cellsEvaluating Permeability Surface-Area Product as a Measure of Blood-Brain Barrier Permeability in a Murine Model.Disrupting the CXCL12/CXCR4 axis disturbs the characteristics of glioblastoma stem-like cells of rat RG2 glioblastoma.Metabolically stable bradykinin B2 receptor agonists enhance transvascular drug delivery into malignant brain tumors by increasing drug half-life.A review of imaging agent development.Recent progress towards development of effective systemic chemotherapy for the treatment of malignant brain tumors.Rat brain tumor models in experimental neuro-oncology: the C6, 9L, T9, RG2, F98, BT4C, RT-2 and CNS-1 gliomas.The War on Cancer rages on.Arterial input functions in dynamic contrast-enhanced magnetic resonance imaging: which model performs best when assessing breast cancer response?In vivo methods to study uptake of nanoparticles into the brain.Tumor response assessments with diffusion and perfusion MRI.Tracer-kinetic modeling of dynamic contrast-enhanced MRI and CT: a primer.The concordance of MRI and quantitative autoradiography estimates of the transvascular transfer rate constant of albumin in a rat brain tumor modelDynamic contrast-enhanced MRI for oncology drug development.Quantification of Tumor Vascular Permeability and Blood Volume by Positron Emission Tomography.A reproducible model of intramedullary spinal cord tumor in rats bearing RG2 cells.Dynamics of rabbit brain edema in focal lesion and perilesion area after traumatic brain injury: a MRI studyEstimating blood and brain concentrations and blood-to-brain influx by magnetic resonance imaging with step-down infusion of Gd-DTPA in focal transient cerebral ischemia and confirmation by quantitative autoradiography with Gd-[(14)C]DTPA.Dynamic contrast enhanced MRI detects changes in vascular transport rate constants following treatment with thermally-sensitive liposomal doxorubicin.Neoplasia: An Anniversary of Progress.Nanomedicine gets personal.Validation of Microcirculatory Parameters Derived from the Standard Two-Compartment Model with Murine Xenografts Model
P2860
Q30273936-B3060D8F-4636-4575-9FCC-9A4BD2B645A0Q30436125-00550CB8-8086-4741-B96D-6FEE9399F69AQ30484000-80448145-0D29-45E8-A7F3-EF89C1930648Q30764736-DA9E425F-F846-440E-B420-937C8A7A935BQ33697885-2BB6A6F0-B1AC-4DE0-82C3-DBE1B9C6B33AQ34096017-F59B8337-917D-4814-AC3F-B2B8A926716CQ34282239-A63CDB24-6482-4E66-99BA-BD2A33D302FEQ34480549-16C5ACD8-AEA8-4D0C-A61F-DA3961F2FB51Q35108121-982E23AD-963F-4414-80F7-8379A5FE5E2FQ35148152-2691C89A-34A1-441D-B0A3-854A6EE0DD86Q35151828-7D0F67A8-7FC0-4143-845C-CE1361311F8EQ35402503-91DF1C96-55B3-4B95-927B-2E8509ACFF10Q35596205-5F9D35DB-6D82-4F79-AB65-D966ED361ED7Q35812789-AC41A9A4-D230-49E2-85A1-3544E10C052EQ35946168-0A5334D4-8DED-42F9-83E4-1D12F335EF0DQ36143593-79FDBD3D-0B63-462C-9120-FC94A2B418AEQ36267403-C6C21021-1ADA-4848-BA8E-D7D0EC0A62B8Q36974297-92B61BF1-5721-494B-A625-7613BEB69B9AQ37091154-75097685-78EE-423F-B2B6-0D8583583775Q37099056-32893ED7-3B5C-4084-AE3D-882CD0403DBCQ37153084-FE1525B0-F557-46A9-B25D-D301127E502BQ37209324-02EB6124-9B8F-4571-AF7D-421B9E12D8F6Q37214528-2BFEBB89-4ABA-4154-B8BA-231E7D0F0669Q37346039-7AC3F7E8-2C6F-497E-B6D7-41E6B49630FBQ37452837-4AFF4DF3-03E2-4DE0-93A4-EBF354F81A11Q37478602-2D88D4D5-C9A7-4B38-BE09-70CBB3AFC3E3Q37600890-FF39AC3A-659B-44B3-AD26-D49F42B564FEQ37798178-9A2C6056-075C-49B6-9D21-3F1E20D1A47EQ37995577-173A3A9A-E7EC-4F09-B7AC-D37B3757FB91Q38096874-EAB3B793-3EE2-47CE-860A-E729785C202AQ38295979-64A6D621-9860-4FA0-80D5-06CD962F44B2Q38725827-396FC836-63E9-4424-87F4-A09CF552CEA6Q41114248-2FC9CE68-24D9-4672-8341-38FD9CC59481Q42223295-F3BEC9A8-6C7E-472F-84D5-45F89A945B74Q42323028-698E11D5-5344-49EC-8A17-D39B2E703FA3Q42955082-D3C94BAD-B09A-4E8E-AB3A-FD8F0CEC02D8Q46626263-48A6545F-CC86-4963-8BAE-32AF0F6D824AQ46932476-D9C34E03-09B9-40B9-91FC-A877515C5A3AQ51639181-A76BC621-EA8F-408D-A3E4-AEEA5AD18947Q59104248-B95D78E9-9703-404C-8AE1-E179EC983154
P2860
Validation of dynamic contrast-enhanced magnetic resonance imaging-derived vascular permeability measurements using quantitative autoradiography in the RG2 rat brain tumor model.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Validation of dynamic contrast ...... the RG2 rat brain tumor model.
@ast
Validation of dynamic contrast ...... the RG2 rat brain tumor model.
@en
type
label
Validation of dynamic contrast ...... the RG2 rat brain tumor model.
@ast
Validation of dynamic contrast ...... the RG2 rat brain tumor model.
@en
prefLabel
Validation of dynamic contrast ...... the RG2 rat brain tumor model.
@ast
Validation of dynamic contrast ...... the RG2 rat brain tumor model.
@en
P2093
P2860
P50
P356
P1433
P1476
Validation of dynamic contrast ...... the RG2 rat brain tumor model
@en
P2093
David Thomasson
Edward H Oldfield
Hemant Sarin
Moira C Ferrier
Peter L Choyke
Ryszard M Pluta
Sandeep N Gupta
P2860
P304
P356
10.1593/NEO.07289
P577
2007-07-01T00:00:00Z